Differential gene expression in HIV-infected individuals following ART.
暂无分享,去创建一个
Douglas D. Richman | Marta Massanella | D. Richman | S. Little | M. Massanella | A. Singhania | N. Beliakova-Bethell | R. Pier | S. Lada | C. White | J. Pérez-Santiago | J. Blanco | C. Woelk | Akul Singhania | Josué Pérez-Santiago | Susan J. Little | Christopher H. Woelk | Julià Blanco | Nadejda Beliakova-Bethell | Rose Pier | Steven Lada | Cory H. White
[1] J. Fuscoe,et al. Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver. , 2008, Mitochondrion.
[2] Y. Shen,et al. p53-dependent apoptosis pathways. , 2001, Advances in cancer research.
[3] L. M. Mansky,et al. Tenofovir treatment of primary osteoblasts alters gene expression profiles: implications for bone mineral density loss. , 2010, Biochemical and biophysical research communications.
[4] P. Rustin,et al. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort , 2003, AIDS.
[5] David J. Volsky,et al. Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders , 2011, PLoS pathogens.
[6] Pan Du,et al. lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..
[7] U. Walker,et al. Mitochondrial Toxicity of Tenofovir, Emtricitabine and Abacavir Alone and in Combination with Additional Nucleoside Reverse Transcriptase Inhibitors , 2007, Antiviral therapy.
[8] B. Day,et al. Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective , 2003, Nature Reviews Drug Discovery.
[9] S. Hosseini,et al. Tenofovir renal toxicity targets mitochondria of renal proximal tubules , 2009, Laboratory Investigation.
[10] M. Baker. Digital PCR hits its stride , 2012, Nature Methods.
[11] D. Mitra,et al. Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis , 2005, Cell Death and Differentiation.
[12] T. Kakuda,et al. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. , 2000, Clinical therapeutics.
[13] J. Montaner,et al. Adverse effects of antiretroviral therapy for HIV infection. , 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[14] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[15] Bertrand Friguet,et al. Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[16] L. Chieco‐Bianchi,et al. Dynamics of Epstein–Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy , 2002, AIDS.
[17] Martin Kuiper,et al. BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..
[18] Kristen K. Dang,et al. Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals , 2010, PLoS pathogens.
[19] David A. Cooper,et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors , 1998, AIDS.
[20] C. Fraga,et al. Curcumin induces cell‐arrest and apoptosis in association with the inhibition of constitutively active NF‐κB and STAT3 pathways in Hodgkin's lymphoma cells , 2008, International journal of cancer.
[21] P. Sullivan,et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. , 2008, Annals of internal medicine.
[22] D. Hazuda,et al. HIV-1 antiretroviral drug therapy. , 2012, Cold Spring Harbor perspectives in medicine.
[23] J. Goeman,et al. The transcriptional response to chronic stress and glucocorticoid receptor blockade in the hippocampal dentate gyrus , 2012, Hippocampus.
[24] E. Vittinghoff,et al. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. , 1999, The Journal of infectious diseases.
[25] J. Pineda,et al. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors. , 2007, The Journal of antimicrobial chemotherapy.
[26] R. Choudhury,et al. HIV Infection , Inflammation , Immunosenescence , and Aging , 2011 .
[27] D. Richman,et al. Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery , 2010, AIDS.
[28] E. Appella,et al. Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. , 1992, The Journal of biological chemistry.
[29] Christopher H Woelk,et al. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. , 2012, Journal of psychiatric research.
[30] Matthew J. Stephens,et al. Global effect of PEG-IFN-α and ribavirin on gene expression in PBMC in vitro , 2004 .
[31] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[32] Stella Pelengaris,et al. c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.
[33] Susumu Goto,et al. KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..
[34] Douglas D. Richman,et al. Highly Precise Measurement of HIV DNA by Droplet Digital PCR , 2013, PloS one.
[35] J. Carlis,et al. Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. , 2004, The Journal of infectious diseases.
[36] G. Palù,et al. Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs , 2006, AIDS.
[37] A. Baracca,et al. Oxidative phosphorylation in cancer cells. , 2011, Biochimica et biophysica acta.
[38] J. Fierer,et al. Factors regulated by interferon gamma and hypoxia-inducible factor 1A contribute to responses that protect mice from Coccidioides immitis infection , 2012, BMC Microbiology.
[39] Matthew J. Stephens,et al. Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[40] J. Gallant,et al. Antiretroviral therapy. , 2000, The Hopkins HIV report : a bimonthly newsletter for healthcare providers.
[41] J. Gearhart,et al. Pluripotency redux--advances in stem-cell research. , 2007, The New England journal of medicine.
[42] J. Garcia,et al. Inhibition of Lysosome and Proteasome Function Enhances Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.
[43] R. Lempicki,et al. Diminished Production of Monocyte Proinflammatory Cytokines during Human Immunodeficiency Virus Viremia Is Mediated by Type I Interferons , 2006, Journal of Virology.
[44] R. Siebert,et al. Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2 , 2003, International journal of cancer.
[45] Jeff Mellen,et al. High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number , 2011, Analytical chemistry.
[46] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[47] Debashis Mitra,et al. Differential modulation of mitochondrial OXPHOS system during HIV-1 induced T-cell apoptosis: up regulation of Complex-IV subunit COX-II and its possible implications , 2009, Apoptosis.
[48] E. Rosenberg,et al. Transcriptional Profiling of Cd4 T Cells Identifies Distinct Subgroups of Hiv-1 Elite Controllers , 2022 .
[49] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .